Last reviewed · How we verify

Drug: YAZ flex (SH T00186D)

Bayer · Phase 3 active Small molecule

Drug: YAZ flex (SH T00186D) is a Oral contraceptive (combined hormonal contraceptive) Small molecule drug developed by Bayer. It is currently in Phase 3 development for Contraception, Treatment of premenstrual dysphoric disorder (PMDD).

YAZ flex is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol and drospirenone, with a flexible dosing regimen.

YAZ flex is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol and drospirenone, with a flexible dosing regimen. Used for Contraception, Treatment of premenstrual dysphoric disorder (PMDD).

At a glance

Generic nameDrug: YAZ flex (SH T00186D)
SponsorBayer
Drug classOral contraceptive (combined hormonal contraceptive)
TargetEstrogen and progesterone receptors
ModalitySmall molecule
Therapeutic areaContraception / Women's Health
PhasePhase 3

Mechanism of action

YAZ flex contains ethinyl estradiol (estrogen) and drospirenone (progestin with antimineralocorticoid activity). The hormones suppress the luteinizing hormone (LH) surge needed for ovulation and thicken cervical mucus to prevent sperm penetration. The flexible regimen allows users to adjust the number of active pills taken consecutively before the hormone-free interval, providing personalized cycle control.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Drug: YAZ flex (SH T00186D)

What is Drug: YAZ flex (SH T00186D)?

Drug: YAZ flex (SH T00186D) is a Oral contraceptive (combined hormonal contraceptive) drug developed by Bayer, indicated for Contraception, Treatment of premenstrual dysphoric disorder (PMDD).

How does Drug: YAZ flex (SH T00186D) work?

YAZ flex is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol and drospirenone, with a flexible dosing regimen.

What is Drug: YAZ flex (SH T00186D) used for?

Drug: YAZ flex (SH T00186D) is indicated for Contraception, Treatment of premenstrual dysphoric disorder (PMDD).

Who makes Drug: YAZ flex (SH T00186D)?

Drug: YAZ flex (SH T00186D) is developed by Bayer (see full Bayer pipeline at /company/bayer).

What drug class is Drug: YAZ flex (SH T00186D) in?

Drug: YAZ flex (SH T00186D) belongs to the Oral contraceptive (combined hormonal contraceptive) class. See all Oral contraceptive (combined hormonal contraceptive) drugs at /class/oral-contraceptive-combined-hormonal-contraceptive.

What development phase is Drug: YAZ flex (SH T00186D) in?

Drug: YAZ flex (SH T00186D) is in Phase 3.

What are the side effects of Drug: YAZ flex (SH T00186D)?

Common side effects of Drug: YAZ flex (SH T00186D) include Nausea, Headache, Breast tenderness, Breakthrough bleeding, Mood changes.

What does Drug: YAZ flex (SH T00186D) target?

Drug: YAZ flex (SH T00186D) targets Estrogen and progesterone receptors and is a Oral contraceptive (combined hormonal contraceptive).

Related